Related Experiment Video
Updated: Jul 9, 2026
09:42
Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research
Published on: April 19, 2017
Imiquimod: mode of action
1Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine and Department of Dermatology, Julius-Maximilians-University, Würzburg, Germany. michael.schoen@virchow.uni-wuerzburg.de
The British Journal of Dermatology
|December 11, 2007
Summary
Imiquimod, an immune-response modifier, activates toll-like receptors (TLR) 7 and 8, initiating an anti-tumor response. It also affects adenosine receptors and induces apoptosis, contributing to its broad efficacy.
Area of Science:
- Immunology
- Pharmacology
- Molecular Biology
Background:
- Imiquimod, a nucleoside analogue, demonstrates efficacy against various tumors.
- Understanding imiquimod's mechanism of action is crucial for its therapeutic application.
Purpose of the Study:
- To elucidate the multifaceted mechanisms underlying imiquimod's anti-tumor activity.
Main Methods:
- The study focuses on the biological effects of imiquimod, particularly its interactions with toll-like receptors (TLR) and adenosine receptors.
- Mechanisms investigated include nuclear factor-kappa B (NF-kappaB) activation, cytokine induction, and apoptosis pathways.
Main Results:
- Imiquimod activates toll-like receptors (TLR) 7 and 8, leading to nuclear factor-kappa B (NF-kappaB) activation, cytokine induction, and a T-helper (Th1)-weighted anti-tumor immune response.
- It also interferes with adenosine receptor signaling, reducing adenylyl cyclase activity and augmenting pro-inflammatory responses.
- At higher concentrations, imiquimod induces tumor cell apoptosis via caspase activation and B cell lymphoma/leukemia protein (Bcl)-2 pathways.
Conclusions:
- Imiquimod exhibits synergistic anti-tumor activity through multiple mechanisms, including immune activation, modulation of signaling pathways, and direct apoptosis induction.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:30Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.